Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from Indoco Remedies Limited ( (IN:INDOCO) ) is now available.
Indoco Remedies Limited has received a notice from the GST Authority regarding a potential demand of Rs. 849.80 Lakhs for GST liabilities related to the period from 2021-2022. While the company plans to respond appropriately and does not anticipate this demand to materialize as a financial liability, it will keep stakeholders informed of any significant developments.
More about Indoco Remedies Limited
Indoco Remedies Limited is a pharmaceutical company involved in the development, manufacture, and marketing of pharmaceutical formulations and active pharmaceutical ingredients. The company operates in the healthcare industry, focusing on domestic and international markets with a diverse range of therapeutic segments.
YTD Price Performance: -20.02%
Average Trading Volume: 7,238
Current Market Cap: 25.95B INR
Find detailed analytics on INDOCO stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue